Request Demo
Last update 20 Mar 2025
DC05F01
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism fascin inhibitors(fascin actin-bundling protein 1 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with DC05F01NCT06873555
Phase Ib/IIa Multicenter, Open-Label Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of DC05F01 in Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors
NCT06873542
An Open-Label, Dose-Escalation Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors
CTR20221006
评价DC05F01在中国晚期或转移性实体瘤患者中的安全性、耐受性、药代动力学特征及初步疗效的开放、剂量探索的Ⅰ期临床试验
[Translation] An open-label, dose-finding Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of DC05F01 in Chinese patients with advanced or metastatic solid tumors
100 Clinical Results associated with DC05F01
Login to view more data
100 Translational Medicine associated with DC05F01
Login to view more data
100 Patents (Medical) associated with DC05F01
Login to view more data
100 Deals associated with DC05F01
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 11 Sep 2024 | |
| Ovarian Epithelial Carcinoma | Phase 2 | China | 11 Sep 2024 | |
| Small cell lung cancer limited stage | Phase 2 | China | 11 Sep 2024 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | China | 08 Jul 2022 | |
| Metastatic Solid Tumor | Phase 1 | China | 08 Jul 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free